Učitavanje...

LC-MS/MS assay for the simultaneous quantitation of the ATM inhibitor AZ31 and the ATR inhibitor AZD6738 in mouse plasma

The ATM kinase inhibitor AZ31 and ATR kinase inhibitor AZD6738 are in various phases of preclinical and clinical evaluation for their ability to potentiate chemoradiation. To support the preclinical evaluation of their pharmacokinetics, we developed and validated an LC-MS/MS assay for the simultaneo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Pharm Biomed Anal
Glavni autori: Kiesel, Brian F., Shogan, Jeffrey C., Rachid, Madani, Parise, Robert A., Vendetti, Frank P., Bakkenist, Christopher J., Beumer, Jan H.
Format: Artigo
Jezik:Inglês
Izdano: 2017
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5357441/
https://ncbi.nlm.nih.gov/pubmed/28213176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpba.2017.01.055
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!